On July 13, 2021, ASTHO issued a statement of support for President Joe Biden’s nomination of Rahul Gupta, MD, MPH, MBA, FACP, to serve as the Director of the Office of National Drug Control Policy.
On May 19, 2021, ASTHO and Wanderly announced the launch of StaffUP, a new program for rapid, on-demand recruiting for governmental public health agencies.
On April 6, 2021, ASTHO released a Board-approved policy statement addressing structural racism as a necessary component in achieving optimal health for all.
On Jan. 15, 2021, ASTHO released a statement of support for President-Elect Joe Biden's American Rescue Plan, noting that the organization is looking forward to working collaboratively with the new administration to achieve the public ...
On Aug. 11, 2022, ASTHO's Chief Medical Officer issued a statement of support for CDC's new COVID-19 guidelines.
A joint statement on transitioning away from universal case investigation and contact tracing for individual cases of COVID-19 by public health agencies.
On Sept. 3, 2020, Rachel Levine, MD, ASTHO President and Secretary of Health for Pennsylvania, issued a statement of concern and called for rigorous scientific testing in response to comments from federal leadership that implied a COVID-19 ...
On Aug. 13, 2020, ASTHO and the National Coalition of STD Directors announced that their joint venture, Making Content: A Training for COVID-19 Contact Tracers has been awarded a Power of A Silver Award by the American Society of ...
On July 16, 2020, ASTHO announced the release of a COVID-19 issue guide that delves into the evolving role and function of technology in this pandemic response. Particularly as it relates to contact tracing, case investigation, and use of ...
On July 16, 2020, ASTHO announced that Pennsylvania Secretary of Health Rachel Levine, MD, has been appointed to the position of ASTHO President.